Biomedicine & Pharmacotherapy

Toxicology and Safety Assessment

Toxicology and safety assessment play a critical role in evaluating the potential harmful effects of drugs, chemicals, and biologics, ensuring safe therapeutic use. Toxicological studies examine acute, subchronic, and chronic toxicity, genotoxicity, carcinogenicity, reproductive toxicity, and immunotoxicity using in vitro assays, in vivo models, and computational predictions. Current challenges include predicting human responses from preclinical models, understanding species-specific differences, and addressing complex mechanisms of toxicity at the molecular and cellular level. Regulatory requirements demand rigorous assessment and documentation of safety profiles before clinical testing and market approval. Emerging trends include the use of organ-on-chip systems, three-dimensional tissue cultures, and computational toxicology to improve predictive accuracy while reducing animal testing. Integration of omics technologies allows identification of biomarkers for early detection of toxic effects, enhancing risk assessment and personalized safety strategies. Pharmacovigilance post-marketing continues to monitor adverse events, drug-drug interactions, and long-term safety, contributing to continuous improvement of therapeutic protocols. Advances in toxicogenomics, predictive modeling, and machine learning improve the understanding of dose-response relationships, mechanisms of action, and interindividual variability. Overall, toxicology and safety assessment provide the scientific foundation to ensure that drugs and therapeutic interventions achieve maximum efficacy while minimizing risk, supporting regulatory compliance, patient safety, and innovation in modern pharmacotherapy.